SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study

<p><strong>Background:</strong> Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling.</p> <p><strong>Methods:</strong> The primary outcome was t...

Full description

Bibliographic Details
Main Authors: COVIDSurg Collaborative, GlobalSurg Collaborative, Gacaferi, H
Format: Journal article
Language:English
Published: Oxford University Press 2021
_version_ 1826289144714756096
author COVIDSurg Collaborative
GlobalSurg Collaborative
Gacaferi, H
author_facet COVIDSurg Collaborative
GlobalSurg Collaborative
Gacaferi, H
author_sort COVIDSurg Collaborative
collection OXFORD
description <p><strong>Background:</strong> Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling.</p> <p><strong>Methods:</strong> The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on postoperative SARS-CoV-2 rates and mortality in an international cohort study (surgical patients), and community SARS-CoV-2 incidence and case fatality data (general population). NNV estimates were stratified by age (18–49, 50–69, 70 or more years) and type of surgery. Best- and worst-case scenarios were used to describe uncertainty.</p> <p><strong>Results:</strong> NNVs were more favourable in surgical patients than the general population. The most favourable NNVs were in patients aged 70 years or more needing cancer surgery (351; best case 196, worst case 816) or non-cancer surgery (733; best case 407, worst case 1664). Both exceeded the NNV in the general population (1840; best case 1196, worst case 3066). NNVs for surgical patients remained favourable at a range of SARS-CoV-2 incidence rates in sensitivity analysis modelling. Globally, prioritizing preoperative vaccination of patients needing elective surgery ahead of the general population could prevent an additional 58 687 (best case 115 007, worst case 20 177) COVID-19-related deaths in 1 year.</p> <p><strong>Conclusion:</strong> As global roll out of SARS-CoV-2 vaccination proceeds, patients needing elective surgery should be prioritized ahead of the general population.</p>
first_indexed 2024-03-07T02:24:25Z
format Journal article
id oxford-uuid:a51aac2d-94e9-40b9-a271-7131d6b86a1e
institution University of Oxford
language English
last_indexed 2024-03-07T02:24:25Z
publishDate 2021
publisher Oxford University Press
record_format dspace
spelling oxford-uuid:a51aac2d-94e9-40b9-a271-7131d6b86a1e2022-03-27T02:38:13ZSARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a51aac2d-94e9-40b9-a271-7131d6b86a1eEnglishSymplectic ElementsOxford University Press2021COVIDSurg CollaborativeGlobalSurg CollaborativeGacaferi, H<p><strong>Background:</strong> Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling.</p> <p><strong>Methods:</strong> The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on postoperative SARS-CoV-2 rates and mortality in an international cohort study (surgical patients), and community SARS-CoV-2 incidence and case fatality data (general population). NNV estimates were stratified by age (18–49, 50–69, 70 or more years) and type of surgery. Best- and worst-case scenarios were used to describe uncertainty.</p> <p><strong>Results:</strong> NNVs were more favourable in surgical patients than the general population. The most favourable NNVs were in patients aged 70 years or more needing cancer surgery (351; best case 196, worst case 816) or non-cancer surgery (733; best case 407, worst case 1664). Both exceeded the NNV in the general population (1840; best case 1196, worst case 3066). NNVs for surgical patients remained favourable at a range of SARS-CoV-2 incidence rates in sensitivity analysis modelling. Globally, prioritizing preoperative vaccination of patients needing elective surgery ahead of the general population could prevent an additional 58 687 (best case 115 007, worst case 20 177) COVID-19-related deaths in 1 year.</p> <p><strong>Conclusion:</strong> As global roll out of SARS-CoV-2 vaccination proceeds, patients needing elective surgery should be prioritized ahead of the general population.</p>
spellingShingle COVIDSurg Collaborative
GlobalSurg Collaborative
Gacaferi, H
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study
title SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study
title_full SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study
title_fullStr SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study
title_full_unstemmed SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study
title_short SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study
title_sort sars cov 2 vaccination modelling for safe surgery to save lives data from an international prospective cohort study
work_keys_str_mv AT covidsurgcollaborative sarscov2vaccinationmodellingforsafesurgerytosavelivesdatafromaninternationalprospectivecohortstudy
AT globalsurgcollaborative sarscov2vaccinationmodellingforsafesurgerytosavelivesdatafromaninternationalprospectivecohortstudy
AT gacaferih sarscov2vaccinationmodellingforsafesurgerytosavelivesdatafromaninternationalprospectivecohortstudy